Cargando…
An Individual’s Lived Experiences of Taking Cannabis-Based Medicinal Products (CBMPs) to Treat Anxiety
This report documents the case of a patient (the author) participating in a clinical trial of medical cannabis (Cannabis sativa L.)—the Sapphire Access Scheme, run by the Sapphire Medical Clinic as part of the UK Medical Cannabis Registry—to explore the impacts of cannabis-based medicinal products (...
Autor principal: | Hurn, Samantha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10530413/ https://www.ncbi.nlm.nih.gov/pubmed/37754635 http://dx.doi.org/10.3390/ijerph20186776 |
Ejemplares similares
-
Clinical outcome data of anxiety patients treated with cannabis-based medicinal products in the United Kingdom: a cohort study from the UK Medical Cannabis Registry
por: Rifkin-Zybutz, Raphael, et al.
Publicado: (2023) -
Medicinal use of cannabis based products and cannabinoids
por: Freeman, Tom P, et al.
Publicado: (2019) -
A Regulatory Take on Cannabis and Cannabinoids for Medicinal use in the European Union
por: Lipnik-Štangelj, Metoda, et al.
Publicado: (2020) -
Clinical Outcome Data of Children Treated with Cannabis-Based Medicinal Products for Treatment Resistant Epilepsy—Analysis from the UK Medical Cannabis Registry
por: Erridge, Simon, et al.
Publicado: (2023) -
Cannabis, Cannabinoids and Cannabis-Based Medicines in Cancer
Care
por: Abrams, Donald I.
Publicado: (2022)